Exact Sciences stockholders approve acquisition by Abbott
MLex Summary: Exact Sciences, a provider of cancer screening and diagnostic tests, said its stockholders approved its proposed sale to Abbott. At a special meeting of stockholders, preliminary results showed that more than...To view the full article, register now.
Already a subscriber? Click here to view full article